• 1. Glycosynthase-based synthesis of xylo-oligosaccharides using an engineered retaining xylanase from Cellulomonas fimi
  Young-Wan Kim,David T. Fox,Omid Hekmat,Terrence Kantner,Lawrence P. McIntosh,R. Antony J. Warren,Stephen G. Withers Org. Biomol. Chem. 2006 4 2025
• 2. Chemo-enzymatic synthesis of 4-methylumbelliferyl β-(1→4)-d-xylooligosides: new substrates for β-d-xylanase assays
  Elena V. Eneyskaya,Dina R. Ivanen,Konstantin A. Shabalin,Anna A. Kulminskaya,Leon V. Backinowsky,Harry Brumer III,Kirill N. Neustroev Org. Biomol. Chem. 2005 3 146
• 3. Studies on the magnetic crossover in five-co-ordinate complexes of iron(II), cobalt(II), and nickel(II). Part I
  W. S. J. Kelly,G. H. Ford,S. M. Nelson J. Chem. Soc. A 1971 388

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Glycosyl compounds

Introduction to 4-Nitrophenyl β-D-xylopyranoside (CAS No. 2001-96-9)

4-Nitrophenyl β-D-xylopyranoside, with the chemical formula C₁₁H₁₁O₇N, is a well-documented glycoside derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, identified by its CAS number CAS No. 2001-96-9, is particularly valued for its structural properties and potential applications in synthetic chemistry and bioconjugation techniques.

The molecular structure of 4-Nitrophenyl β-D-xylopyranoside consists of a β-D-xylopyranose moiety linked to a 4-nitrophenyl group. This configuration makes it an excellent substrate for studying glycosidase enzymes and their mechanisms, which are crucial in various biological processes, including carbohydrate metabolism and cell signaling. The nitrophenyl group not only enhances the solubility of the compound in polar solvents but also provides a reactive site for further chemical modifications, making it a versatile tool in medicinal chemistry.

In recent years, 4-Nitrophenyl β-D-xylopyranoside has been extensively investigated for its role in developing novel glycosidase inhibitors. These inhibitors are of paramount importance in the treatment of diseases associated with aberrant glycosylation, such as cancer and inflammatory disorders. The ability of this compound to mimic natural glycosides while being resistant to enzymatic degradation has opened new avenues for therapeutic intervention.

One of the most compelling aspects of 4-Nitrophenyl β-D-xylopyranoside is its utility in synthetic biology and biocatalysis. Researchers have leveraged this compound to develop enzymatic cascades that facilitate the efficient synthesis of complex carbohydrates. These advancements are particularly relevant in the production of biomaterials and pharmaceuticals, where precise control over glycosylation patterns is essential.

The application of 4-Nitrophenyl β-D-xylopyranoside extends beyond academic research; it has found practical use in industrial settings as well. For instance, it serves as a key intermediate in the synthesis of high-value glycoconjugates used in vaccines and diagnostic agents. The stability and reactivity profile of this compound make it an ideal candidate for large-scale manufacturing processes.

Recent studies have also highlighted the potential of 4-Nitrophenyl β-D-xylopyranoside in drug discovery efforts. By serving as a scaffold for structure-activity relationship (SAR) studies, researchers have been able to identify novel pharmacophores that could lead to the development of next-generation therapeutics. The nitrophenyl group, in particular, has been shown to enhance binding affinity and selectivity when incorporated into drug molecules.

The environmental impact of using CAS No. 2001-96-9 has also been a point of interest. Unlike some traditional synthetic methods that rely on hazardous reagents, the production of 4-Nitrophenyl β-D-xylopyranoside can be achieved under mild conditions with high yields. This aligns with the growing trend toward green chemistry practices, where sustainability and environmental responsibility are paramount.

In conclusion, 4-Nitrophenyl β-D-xylopyranoside represents a significant advancement in glycoscience and pharmaceutical chemistry. Its unique structural features and functional properties make it an invaluable tool for researchers across multiple disciplines. As our understanding of glycosylation continues to evolve, compounds like this will undoubtedly play a central role in shaping the future of medicine and biotechnology.

• 1223-07-0(4-Nitrophenyl a-L-Arabinopyranoside)
• 129411-62-7(p-Nitrophenyl β-D-Cellotetraoside)
• 16790-33-3(4-Nitrophenyl 2-O-β-D-Glucopyranosyl-β-D-glucopyranoside)
• 129411-63-8(p-Nitrophenyl b-D-Cellopentaoside)
• 106927-48-4(p-Nitrophenyl b-D-Cellotrioside)
• 10357-27-4(p-Nitrophenyl α-D-mannopyranoside)
• 10231-84-2(p-Nitrophenyl a-L-Fucopyranoside)
• 104872-92-6(D-Glucopyranoside,4-nitrophenyl 6-O-b-D-galactopyranosyl-)
• 18918-31-5(4-Nitrophenyl α-L-Rhamnopyranoside)
• 147103-31-9(4-Nitrophenyl 2-O-α-D-Glucopyranosyl-α-D-glucopyranoside)